PBS approval for new once-a-day diabetes medications 9 December 2014 New once-a-day fixed-dose medications for people with type 2 diabetes have been approved for inclusion on the Pharmaceutical Benefits Scheme (PBS). The two new treatments are linagliptin with metformin (sold as Trajenta Duo), and saxagliptin with metformin (sold as Kombiglyze). Federal Health Minister Peter Dutton said that while people with type 2 diabetes already have access to the individual medications through the PBS, some need to use a combination of medicines to treat their diabetes. “With the combination dose now listed on the PBS, these patients will save up to $36.90 every time they get a script filled because they will only have to buy one fixed dose medicine instead of two,†Mr Dutton said. The new treatments are available via prescription. For more information, please contact your doctor or endocrinologist.
News 24 July 2026 GLP-1 RA safety update for rare but severe eye disorders The Therapeutic Good Administration has updated GLP-1 RA product warnings because of their potential to cause a rare but severe eye disorder. The glucagon-like peptide-1 receptor agonist... Continue Reading
Blog 22 July 2026 Living Out Loud: how Australia spoke up for National Diabetes Week 2026 From 12 to 18 July, Australians living with diabetes, alongside their carers, researchers, health professionals and clinicians, did something powerful. They... Continue Reading
News 20 July 2026 Response to media reports from 60 Minutes, The Sydney Morning Herald, and The Age regarding regulation of diabetes technologies The safety of people living with diabetes must always come first. For many Australians, technologies such as insulin pumps and continuous glucose monitors are essential tools that help prevent dangerous high and low blood glucose levels, reduce the daily burden of living with diabetes and improve long-term health outcomes. For some individuals they can be life-changing or even life-saving. Continue Reading
